nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—CYP1A2—Dacarbazine—muscle cancer	0.269	0.404	CbGbCtD
Cyclobenzaprine—CYP1A2—Etoposide—muscle cancer	0.132	0.198	CbGbCtD
Cyclobenzaprine—CYP3A4—Vincristine—muscle cancer	0.0753	0.113	CbGbCtD
Cyclobenzaprine—CYP2D6—Doxorubicin—muscle cancer	0.074	0.111	CbGbCtD
Cyclobenzaprine—CYP3A4—Etoposide—muscle cancer	0.069	0.104	CbGbCtD
Cyclobenzaprine—CYP3A4—Doxorubicin—muscle cancer	0.0471	0.0706	CbGbCtD
Cyclobenzaprine—Agranulocytosis—Dactinomycin—muscle cancer	0.00228	0.00684	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Vincristine—muscle cancer	0.00226	0.00676	CcSEcCtD
Cyclobenzaprine—Hepatitis—Dactinomycin—muscle cancer	0.00219	0.00658	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Dactinomycin—muscle cancer	0.00218	0.00653	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Vincristine—muscle cancer	0.00215	0.00645	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Vincristine—muscle cancer	0.00214	0.00641	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Vincristine—muscle cancer	0.00214	0.00641	CcSEcCtD
Cyclobenzaprine—Stomatitis—Vincristine—muscle cancer	0.00213	0.00638	CcSEcCtD
Cyclobenzaprine—Sweating—Vincristine—muscle cancer	0.00209	0.00627	CcSEcCtD
Cyclobenzaprine—Ageusia—Doxorubicin—muscle cancer	0.00202	0.00607	CcSEcCtD
Cyclobenzaprine—Dysarthria—Methotrexate—muscle cancer	0.002	0.006	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Vincristine—muscle cancer	0.00195	0.00585	CcSEcCtD
Cyclobenzaprine—Hallucination—Vincristine—muscle cancer	0.00195	0.00585	CcSEcCtD
Cyclobenzaprine—Alopecia—Dactinomycin—muscle cancer	0.00194	0.00581	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Etoposide—muscle cancer	0.00188	0.00565	CcSEcCtD
Cyclobenzaprine—Thinking abnormal—Doxorubicin—muscle cancer	0.00179	0.00537	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Dactinomycin—muscle cancer	0.00177	0.00531	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Etoposide—muscle cancer	0.00174	0.00523	CcSEcCtD
Cyclobenzaprine—Dysarthria—Doxorubicin—muscle cancer	0.00173	0.0052	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Etoposide—muscle cancer	0.00173	0.0052	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Etoposide—muscle cancer	0.00173	0.0052	CcSEcCtD
Cyclobenzaprine—Alopecia—Vincristine—muscle cancer	0.00173	0.00519	CcSEcCtD
Cyclobenzaprine—Stomatitis—Etoposide—muscle cancer	0.00172	0.00517	CcSEcCtD
Cyclobenzaprine—Jaundice—Etoposide—muscle cancer	0.00172	0.00517	CcSEcCtD
Cyclobenzaprine—Malaise—Dactinomycin—muscle cancer	0.00172	0.00516	CcSEcCtD
Cyclobenzaprine—Leukopenia—Dactinomycin—muscle cancer	0.00171	0.00512	CcSEcCtD
Cyclobenzaprine—Gynaecomastia—Methotrexate—muscle cancer	0.00169	0.00508	CcSEcCtD
Cyclobenzaprine—Atrioventricular block—Doxorubicin—muscle cancer	0.00169	0.00507	CcSEcCtD
Cyclobenzaprine—Gait disturbance—Doxorubicin—muscle cancer	0.00168	0.00504	CcSEcCtD
Cyclobenzaprine—Coordination abnormal—Doxorubicin—muscle cancer	0.00167	0.00501	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Etoposide—muscle cancer	0.00165	0.00495	CcSEcCtD
Cyclobenzaprine—Myalgia—Dactinomycin—muscle cancer	0.00163	0.00487	CcSEcCtD
Cyclobenzaprine—Discomfort—Dactinomycin—muscle cancer	0.00161	0.00481	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Etoposide—muscle cancer	0.00158	0.00474	CcSEcCtD
Cyclobenzaprine—Agitation—Vincristine—muscle cancer	0.00157	0.0047	CcSEcCtD
Cyclobenzaprine—Oedema—Dactinomycin—muscle cancer	0.00156	0.00467	CcSEcCtD
Cyclobenzaprine—Vertigo—Vincristine—muscle cancer	0.00153	0.00459	CcSEcCtD
Cyclobenzaprine—Leukopenia—Vincristine—muscle cancer	0.00153	0.00458	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Dactinomycin—muscle cancer	0.00153	0.00457	CcSEcCtD
Cyclobenzaprine—Anorexia—Dactinomycin—muscle cancer	0.00149	0.00445	CcSEcCtD
Cyclobenzaprine—Convulsion—Vincristine—muscle cancer	0.00148	0.00443	CcSEcCtD
Cyclobenzaprine—Hypertension—Vincristine—muscle cancer	0.00147	0.00442	CcSEcCtD
Cyclobenzaprine—Myalgia—Vincristine—muscle cancer	0.00145	0.00435	CcSEcCtD
Cyclobenzaprine—Hypertonia—Doxorubicin—muscle cancer	0.00144	0.00431	CcSEcCtD
Cyclobenzaprine—Mental disability—Doxorubicin—muscle cancer	0.00142	0.00427	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00142	0.00426	CcSEcCtD
Cyclobenzaprine—Alopecia—Etoposide—muscle cancer	0.0014	0.00421	CcSEcCtD
Cyclobenzaprine—Cerebrovascular accident—Methotrexate—muscle cancer	0.0014	0.0042	CcSEcCtD
Cyclobenzaprine—Oedema—Vincristine—muscle cancer	0.00139	0.00417	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Vincristine—muscle cancer	0.00139	0.00417	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Methotrexate—muscle cancer	0.00137	0.00412	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Vincristine—muscle cancer	0.00136	0.00409	CcSEcCtD
Cyclobenzaprine—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00136	0.00408	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Dactinomycin—muscle cancer	0.00136	0.00406	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Etoposide—muscle cancer	0.00135	0.00406	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Vincristine—muscle cancer	0.00135	0.00403	CcSEcCtD
Cyclobenzaprine—Fatigue—Dactinomycin—muscle cancer	0.00134	0.00403	CcSEcCtD
Cyclobenzaprine—Vascular purpura—Doxorubicin—muscle cancer	0.00133	0.00399	CcSEcCtD
Cyclobenzaprine—Anorexia—Vincristine—muscle cancer	0.00133	0.00398	CcSEcCtD
Cyclobenzaprine—Irritability—Methotrexate—muscle cancer	0.00131	0.00393	CcSEcCtD
Cyclobenzaprine—Hypotension—Vincristine—muscle cancer	0.0013	0.0039	CcSEcCtD
Cyclobenzaprine—Ataxia—Methotrexate—muscle cancer	0.00129	0.00387	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Dactinomycin—muscle cancer	0.00128	0.00385	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Etoposide—muscle cancer	0.00128	0.00384	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00127	0.00382	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00127	0.0038	CcSEcCtD
Cyclobenzaprine—Insomnia—Vincristine—muscle cancer	0.00126	0.00377	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Vincristine—muscle cancer	0.00125	0.00375	CcSEcCtD
Cyclobenzaprine—Malaise—Etoposide—muscle cancer	0.00125	0.00374	CcSEcCtD
Cyclobenzaprine—Vertigo—Etoposide—muscle cancer	0.00124	0.00372	CcSEcCtD
Cyclobenzaprine—Leukopenia—Etoposide—muscle cancer	0.00124	0.00371	CcSEcCtD
Cyclobenzaprine—Purpura—Doxorubicin—muscle cancer	0.00124	0.0037	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Dactinomycin—muscle cancer	0.00123	0.00369	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Etoposide—muscle cancer	0.00121	0.00364	CcSEcCtD
Cyclobenzaprine—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00121	0.00364	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Vincristine—muscle cancer	0.00121	0.00363	CcSEcCtD
Cyclobenzaprine—Fatigue—Vincristine—muscle cancer	0.0012	0.0036	CcSEcCtD
Cyclobenzaprine—Convulsion—Etoposide—muscle cancer	0.0012	0.00359	CcSEcCtD
Cyclobenzaprine—Hypertension—Etoposide—muscle cancer	0.00119	0.00358	CcSEcCtD
Cyclobenzaprine—Constipation—Vincristine—muscle cancer	0.00119	0.00357	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Doxorubicin—muscle cancer	0.00119	0.00357	CcSEcCtD
Cyclobenzaprine—Diplopia—Doxorubicin—muscle cancer	0.00119	0.00357	CcSEcCtD
Cyclobenzaprine—Chest pain—Etoposide—muscle cancer	0.00118	0.00353	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Methotrexate—muscle cancer	0.00118	0.00353	CcSEcCtD
Cyclobenzaprine—Discomfort—Etoposide—muscle cancer	0.00116	0.00348	CcSEcCtD
Cyclobenzaprine—Face oedema—Doxorubicin—muscle cancer	0.00115	0.00344	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Dactinomycin—muscle cancer	0.00115	0.00344	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Vincristine—muscle cancer	0.00114	0.00341	CcSEcCtD
Cyclobenzaprine—Confusional state—Etoposide—muscle cancer	0.00114	0.00341	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Methotrexate—muscle cancer	0.00113	0.00338	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Etoposide—muscle cancer	0.00113	0.00338	CcSEcCtD
Cyclobenzaprine—Ataxia—Doxorubicin—muscle cancer	0.00112	0.00335	CcSEcCtD
Cyclobenzaprine—Asthenia—Dactinomycin—muscle cancer	0.00112	0.00335	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Etoposide—muscle cancer	0.0011	0.00331	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Methotrexate—muscle cancer	0.0011	0.00331	CcSEcCtD
Cyclobenzaprine—Tachycardia—Etoposide—muscle cancer	0.0011	0.0033	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Vincristine—muscle cancer	0.0011	0.0033	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Methotrexate—muscle cancer	0.00109	0.00328	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Etoposide—muscle cancer	0.00109	0.00327	CcSEcCtD
Cyclobenzaprine—Anorexia—Etoposide—muscle cancer	0.00108	0.00322	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Dactinomycin—muscle cancer	0.00107	0.0032	CcSEcCtD
Cyclobenzaprine—Drowsiness—Methotrexate—muscle cancer	0.00106	0.00318	CcSEcCtD
Cyclobenzaprine—Hypotension—Etoposide—muscle cancer	0.00105	0.00316	CcSEcCtD
Cyclobenzaprine—Gastritis—Doxorubicin—muscle cancer	0.00105	0.00316	CcSEcCtD
Cyclobenzaprine—Stomatitis—Methotrexate—muscle cancer	0.00103	0.0031	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Vincristine—muscle cancer	0.00103	0.00308	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Doxorubicin—muscle cancer	0.00102	0.00305	CcSEcCtD
Cyclobenzaprine—Sweating—Methotrexate—muscle cancer	0.00102	0.00304	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Etoposide—muscle cancer	0.00101	0.00304	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Etoposide—muscle cancer	0.00101	0.00301	CcSEcCtD
Cyclobenzaprine—Somnolence—Etoposide—muscle cancer	0.001	0.00301	CcSEcCtD
Cyclobenzaprine—Asthenia—Vincristine—muscle cancer	0.000999	0.00299	CcSEcCtD
Cyclobenzaprine—Vomiting—Dactinomycin—muscle cancer	0.000991	0.00297	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Methotrexate—muscle cancer	0.000989	0.00296	CcSEcCtD
Cyclobenzaprine—Rash—Dactinomycin—muscle cancer	0.000983	0.00295	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Etoposide—muscle cancer	0.000981	0.00294	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Doxorubicin—muscle cancer	0.000977	0.00293	CcSEcCtD
Cyclobenzaprine—Fatigue—Etoposide—muscle cancer	0.000973	0.00291	CcSEcCtD
Cyclobenzaprine—Constipation—Etoposide—muscle cancer	0.000965	0.00289	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000956	0.00287	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Vincristine—muscle cancer	0.000953	0.00286	CcSEcCtD
Cyclobenzaprine—Hepatitis—Methotrexate—muscle cancer	0.000951	0.00285	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Doxorubicin—muscle cancer	0.000951	0.00285	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Methotrexate—muscle cancer	0.000944	0.00283	CcSEcCtD
Cyclobenzaprine—Weight increased—Doxorubicin—muscle cancer	0.000936	0.00281	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Etoposide—muscle cancer	0.00093	0.00279	CcSEcCtD
Cyclobenzaprine—Nausea—Dactinomycin—muscle cancer	0.000926	0.00277	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Etoposide—muscle cancer	0.000923	0.00276	CcSEcCtD
Cyclobenzaprine—Dizziness—Vincristine—muscle cancer	0.000921	0.00276	CcSEcCtD
Cyclobenzaprine—Drowsiness—Doxorubicin—muscle cancer	0.000917	0.00275	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000899	0.0027	CcSEcCtD
Cyclobenzaprine—Urticaria—Etoposide—muscle cancer	0.000896	0.00269	CcSEcCtD
Cyclobenzaprine—Stomatitis—Doxorubicin—muscle cancer	0.000894	0.00268	CcSEcCtD
Cyclobenzaprine—Jaundice—Doxorubicin—muscle cancer	0.000894	0.00268	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Etoposide—muscle cancer	0.000892	0.00267	CcSEcCtD
Cyclobenzaprine—Tinnitus—Methotrexate—muscle cancer	0.000887	0.00266	CcSEcCtD
Cyclobenzaprine—Vomiting—Vincristine—muscle cancer	0.000885	0.00265	CcSEcCtD
Cyclobenzaprine—Sweating—Doxorubicin—muscle cancer	0.00088	0.00264	CcSEcCtD
Cyclobenzaprine—Rash—Vincristine—muscle cancer	0.000878	0.00263	CcSEcCtD
Cyclobenzaprine—Dermatitis—Vincristine—muscle cancer	0.000877	0.00263	CcSEcCtD
Cyclobenzaprine—Headache—Vincristine—muscle cancer	0.000872	0.00261	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Doxorubicin—muscle cancer	0.000856	0.00257	CcSEcCtD
Cyclobenzaprine—Alopecia—Methotrexate—muscle cancer	0.00084	0.00252	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Etoposide—muscle cancer	0.000831	0.00249	CcSEcCtD
Cyclobenzaprine—Nausea—Vincristine—muscle cancer	0.000827	0.00248	CcSEcCtD
Cyclobenzaprine—Hepatitis—Doxorubicin—muscle cancer	0.000824	0.00247	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000819	0.00246	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Doxorubicin—muscle cancer	0.000817	0.00245	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Methotrexate—muscle cancer	0.000811	0.00243	CcSEcCtD
Cyclobenzaprine—Asthenia—Etoposide—muscle cancer	0.000809	0.00243	CcSEcCtD
Cyclobenzaprine—Pruritus—Etoposide—muscle cancer	0.000798	0.00239	CcSEcCtD
Cyclobenzaprine—Vision blurred—Methotrexate—muscle cancer	0.00078	0.00234	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Etoposide—muscle cancer	0.000772	0.00231	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Methotrexate—muscle cancer	0.000768	0.0023	CcSEcCtD
Cyclobenzaprine—Tinnitus—Doxorubicin—muscle cancer	0.000768	0.0023	CcSEcCtD
Cyclobenzaprine—Malaise—Methotrexate—muscle cancer	0.000747	0.00224	CcSEcCtD
Cyclobenzaprine—Dizziness—Etoposide—muscle cancer	0.000746	0.00224	CcSEcCtD
Cyclobenzaprine—Vertigo—Methotrexate—muscle cancer	0.000744	0.00223	CcSEcCtD
Cyclobenzaprine—Leukopenia—Methotrexate—muscle cancer	0.000741	0.00222	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Doxorubicin—muscle cancer	0.000736	0.0022	CcSEcCtD
Cyclobenzaprine—Alopecia—Doxorubicin—muscle cancer	0.000728	0.00218	CcSEcCtD
Cyclobenzaprine—Convulsion—Methotrexate—muscle cancer	0.000717	0.00215	CcSEcCtD
Cyclobenzaprine—Vomiting—Etoposide—muscle cancer	0.000717	0.00215	CcSEcCtD
Cyclobenzaprine—Rash—Etoposide—muscle cancer	0.000711	0.00213	CcSEcCtD
Cyclobenzaprine—Dermatitis—Etoposide—muscle cancer	0.000711	0.00213	CcSEcCtD
Cyclobenzaprine—Headache—Etoposide—muscle cancer	0.000707	0.00212	CcSEcCtD
Cyclobenzaprine—Flatulence—Doxorubicin—muscle cancer	0.000706	0.00212	CcSEcCtD
Cyclobenzaprine—Chest pain—Methotrexate—muscle cancer	0.000705	0.00211	CcSEcCtD
Cyclobenzaprine—Myalgia—Methotrexate—muscle cancer	0.000705	0.00211	CcSEcCtD
Cyclobenzaprine—Tension—Doxorubicin—muscle cancer	0.000704	0.00211	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Doxorubicin—muscle cancer	0.000702	0.0021	CcSEcCtD
Cyclobenzaprine—Discomfort—Methotrexate—muscle cancer	0.000696	0.00209	CcSEcCtD
Cyclobenzaprine—Nervousness—Doxorubicin—muscle cancer	0.000696	0.00209	CcSEcCtD
Cyclobenzaprine—Confusional state—Methotrexate—muscle cancer	0.000681	0.00204	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Methotrexate—muscle cancer	0.000676	0.00203	CcSEcCtD
Cyclobenzaprine—Vision blurred—Doxorubicin—muscle cancer	0.000676	0.00202	CcSEcCtD
Cyclobenzaprine—Nausea—Etoposide—muscle cancer	0.00067	0.00201	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000665	0.00199	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Methotrexate—muscle cancer	0.000662	0.00198	CcSEcCtD
Cyclobenzaprine—Agitation—Doxorubicin—muscle cancer	0.000659	0.00197	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Methotrexate—muscle cancer	0.000653	0.00196	CcSEcCtD
Cyclobenzaprine—Malaise—Doxorubicin—muscle cancer	0.000647	0.00194	CcSEcCtD
Cyclobenzaprine—Vertigo—Doxorubicin—muscle cancer	0.000644	0.00193	CcSEcCtD
Cyclobenzaprine—Anorexia—Methotrexate—muscle cancer	0.000644	0.00193	CcSEcCtD
Cyclobenzaprine—Syncope—Doxorubicin—muscle cancer	0.000643	0.00193	CcSEcCtD
Cyclobenzaprine—Leukopenia—Doxorubicin—muscle cancer	0.000642	0.00192	CcSEcCtD
Cyclobenzaprine—Palpitations—Doxorubicin—muscle cancer	0.000634	0.0019	CcSEcCtD
Cyclobenzaprine—Hypotension—Methotrexate—muscle cancer	0.000631	0.00189	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Doxorubicin—muscle cancer	0.00063	0.00189	CcSEcCtD
Cyclobenzaprine—Convulsion—Doxorubicin—muscle cancer	0.000621	0.00186	CcSEcCtD
Cyclobenzaprine—Hypertension—Doxorubicin—muscle cancer	0.000619	0.00186	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000616	0.00185	CcSEcCtD
Cyclobenzaprine—Insomnia—Methotrexate—muscle cancer	0.000611	0.00183	CcSEcCtD
Cyclobenzaprine—Myalgia—Doxorubicin—muscle cancer	0.00061	0.00183	CcSEcCtD
Cyclobenzaprine—Chest pain—Doxorubicin—muscle cancer	0.00061	0.00183	CcSEcCtD
Cyclobenzaprine—Anxiety—Doxorubicin—muscle cancer	0.000608	0.00182	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Methotrexate—muscle cancer	0.000607	0.00182	CcSEcCtD
Cyclobenzaprine—Discomfort—Doxorubicin—muscle cancer	0.000603	0.00181	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Methotrexate—muscle cancer	0.000602	0.00181	CcSEcCtD
Cyclobenzaprine—Somnolence—Methotrexate—muscle cancer	0.000601	0.0018	CcSEcCtD
Cyclobenzaprine—Dry mouth—Doxorubicin—muscle cancer	0.000597	0.00179	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Methotrexate—muscle cancer	0.000595	0.00178	CcSEcCtD
Cyclobenzaprine—Confusional state—Doxorubicin—muscle cancer	0.00059	0.00177	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Methotrexate—muscle cancer	0.000587	0.00176	CcSEcCtD
Cyclobenzaprine—Oedema—Doxorubicin—muscle cancer	0.000585	0.00175	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Doxorubicin—muscle cancer	0.000585	0.00175	CcSEcCtD
Cyclobenzaprine—Fatigue—Methotrexate—muscle cancer	0.000583	0.00175	CcSEcCtD
Cyclobenzaprine—Shock—Doxorubicin—muscle cancer	0.000576	0.00173	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000573	0.00172	CcSEcCtD
Cyclobenzaprine—Tachycardia—Doxorubicin—muscle cancer	0.000571	0.00171	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000566	0.0017	CcSEcCtD
Cyclobenzaprine—Anorexia—Doxorubicin—muscle cancer	0.000558	0.00167	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Methotrexate—muscle cancer	0.000557	0.00167	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000553	0.00166	CcSEcCtD
Cyclobenzaprine—Hypotension—Doxorubicin—muscle cancer	0.000547	0.00164	CcSEcCtD
Cyclobenzaprine—Urticaria—Methotrexate—muscle cancer	0.000537	0.00161	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Methotrexate—muscle cancer	0.000534	0.0016	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000533	0.0016	CcSEcCtD
Cyclobenzaprine—Insomnia—Doxorubicin—muscle cancer	0.000529	0.00159	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Doxorubicin—muscle cancer	0.000525	0.00157	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Doxorubicin—muscle cancer	0.000522	0.00156	CcSEcCtD
Cyclobenzaprine—Somnolence—Doxorubicin—muscle cancer	0.00052	0.00156	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Doxorubicin—muscle cancer	0.000515	0.00154	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Doxorubicin—muscle cancer	0.000509	0.00152	CcSEcCtD
Cyclobenzaprine—Fatigue—Doxorubicin—muscle cancer	0.000504	0.00151	CcSEcCtD
Cyclobenzaprine—Constipation—Doxorubicin—muscle cancer	0.0005	0.0015	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Methotrexate—muscle cancer	0.000498	0.00149	CcSEcCtD
Cyclobenzaprine—Asthenia—Methotrexate—muscle cancer	0.000485	0.00145	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Doxorubicin—muscle cancer	0.000482	0.00145	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000478	0.00143	CcSEcCtD
Cyclobenzaprine—Pruritus—Methotrexate—muscle cancer	0.000478	0.00143	CcSEcCtD
Cyclobenzaprine—Urticaria—Doxorubicin—muscle cancer	0.000465	0.00139	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Doxorubicin—muscle cancer	0.000463	0.00139	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Methotrexate—muscle cancer	0.000462	0.00139	CcSEcCtD
Cyclobenzaprine—Dizziness—Methotrexate—muscle cancer	0.000447	0.00134	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Doxorubicin—muscle cancer	0.000431	0.00129	CcSEcCtD
Cyclobenzaprine—Vomiting—Methotrexate—muscle cancer	0.00043	0.00129	CcSEcCtD
Cyclobenzaprine—Rash—Methotrexate—muscle cancer	0.000426	0.00128	CcSEcCtD
Cyclobenzaprine—Dermatitis—Methotrexate—muscle cancer	0.000426	0.00128	CcSEcCtD
Cyclobenzaprine—Headache—Methotrexate—muscle cancer	0.000423	0.00127	CcSEcCtD
Cyclobenzaprine—Asthenia—Doxorubicin—muscle cancer	0.00042	0.00126	CcSEcCtD
Cyclobenzaprine—Pruritus—Doxorubicin—muscle cancer	0.000414	0.00124	CcSEcCtD
Cyclobenzaprine—Nausea—Methotrexate—muscle cancer	0.000401	0.0012	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Doxorubicin—muscle cancer	0.0004	0.0012	CcSEcCtD
Cyclobenzaprine—Dizziness—Doxorubicin—muscle cancer	0.000387	0.00116	CcSEcCtD
Cyclobenzaprine—Vomiting—Doxorubicin—muscle cancer	0.000372	0.00111	CcSEcCtD
Cyclobenzaprine—Rash—Doxorubicin—muscle cancer	0.000369	0.00111	CcSEcCtD
Cyclobenzaprine—Dermatitis—Doxorubicin—muscle cancer	0.000369	0.0011	CcSEcCtD
Cyclobenzaprine—Headache—Doxorubicin—muscle cancer	0.000367	0.0011	CcSEcCtD
Cyclobenzaprine—Nausea—Doxorubicin—muscle cancer	0.000348	0.00104	CcSEcCtD
